Australia's biotech boom to continue
Bad immune cells can turn good
Scientists 'reverse' ageing in mice by improving endurance
Low vitamin D in pregnancy linked to autism-like behaviour
Drug delays disability in secondary progressive MS
Antibody-based lung fibrosis therapy gets a redesign
AdAlta has announced major improvements to the design of its preclinical therapy for lung fibrosis which have enhanced the drug's potency and extended its half-life.
New initiative to propel MTP SMEs
The SME Strategic Innovation Initiative will help Australian medical technology and pharmaceutical companies better prepare themselves to engage with multinational companies.
Personalised cancer vaccine underway at UQ
Researchers have developed a vaccine delivery technology that enables treatment to be tailored for different cancers, improving the precision of cancer immunotherapy.
Australia's biotech boom to continue
The Australian life sciences and biotech industry is witnessing a resurgence in activity, which is expected to continue over the next 12 months.
Bad immune cells can turn good
Scientists have discovered that cells once thought to be useful, and even a liability, could be important tools in the fight against disease — including the...
Australia's biotech boom to continue
The Australian life sciences and biotech industry is witnessing a resurgence in activity, which is expected to continue over the next 12 months.
-
Modular hearing aids: functional, rechargeable, beautiful
A Melbourne researcher has helped design what is claimed to be the world's first modular...
-
-
'Thought control' enables spinal injury patient to ride a bike
Gold Coast researchers are using a 3D computer-simulated biomechanical model and an...
-
-
New drug could halt MS in its tracks
Monash University researchers are about to conduct a study into a drug that may thwart the...
-
Drug delays disability in secondary progressive MS
A new drug is said to slow the progression of disability in secondary progressive multiple sclerosis (MS), according to a double-blind, randomised,...
-
Alzheimer's blood test predicts beta-amyloid in the brain
Scientists have discovered plasma biomarkers that can predict beta-amyloid deposition in the...
-
-
Gene therapy comes of age
Gene therapy is no longer the future of medicine, but is part of the present-day clinical...
-
-
Rare diseases and the power of precision medicine
When molecular biologists Steve Wilton and Sue Fletcher first started exploring dystrophin exon...
-
Bad immune cells can turn good
Scientists have discovered that cells once thought to be useful, and even a liability, could be important tools in the fight against disease...
-
Scientists 'reverse' ageing in mice by improving endurance
Replacing two naturally occurring molecules in the body could reverse symptoms of ageing,...
-
-
Low vitamin D in pregnancy linked to autism-like behaviour
Vitamin D plays an important role in the brain development of children, according to Western...
-
-
Medication caught meddling with the gut microbiome
One in four pharmaceuticals have been found to inhibit the growth of bacteria in the human gut,...
-
CRISPR gene-editing tool targets RNA, tackles dementia
Scientists have used CRISPR gene-editing technology to target RNA — as opposed to DNA — and in the process corrected a protein...
-
DNA scissors can cut RNA as well
Scientists have discovered that Cas9 'DNA scissors' can also readily target RNA, in a...
-
-
Modified gene-editing technique reverses disease without cutting DNA
Californian researchers have developed a modified CRISPR-Cas9 technique that alters the activity,...
-
-
Scientists find possible genetic links to male sexual orientation
While Australia's LGBTIQ+ community celebrates the legalisation of same-sex marriage, US...
-
Award-winning digital innovations for the health sector
The winning entries in the 2015 national iAwards have brought a range of benefits to a variety of sectors — with the health sector being no...
-
From little grants big labs grow
The Monash Institute of Pharmaceutical Sciences has officially opened its new laboratory —...
-
-
A non-exclusive licence agreement for LBT and bioMérieux
LBT Innovations and bioMérieux have converted their exclusive licence...
-
-
UTS opens state-of-the-art health and science building
UTS's Faculty of Science and Graduate School of Health Building - the third major development...
-
